IDH2 mutations were first detected in gliomas by Yan et al. [3]; similar to IDH1 mutations, IDH2 mutation were associated with a better prognosis, although these mutations occurred at considerable lower frequency. The gene discussed is IDH2; the disease is central nervous system cancer.